At the direction of the B.C. Chief Nursing Officer Council a provincial decision support tool (DST) for the management of anaphylaxis, "Anaphylaxis: Initial Emergency Treatment by Nurses (Adult and Pediatric)" has been developed. The provincial DST was developed to ensure that the initial emergency management of anaphylaxis is consistent amongst all nurses across the province, in all settings. The provincial anaphylaxis DST is based upon the World Allergy Organization guidelines and has incorporated the most up-to-date evidence. The BC Immunization Manual, Part 3 - Management of Anaphylaxis in a Non-Hospital Setting has been revised to be consistent with the provincial DST.
Beginning May 2018 BC will begin transitioning to the use of pentavalent rotavirus vaccine (RV5, RotaTeq®) in the infant rotavirus immunization program. The main difference with this product change is the immunization schedule, as the schedule for RotaTeq® is 3 doses, rather than 2 doses of Rotarix®. It is recommended that RotaTeq® be administered at 2, 4 and 6 months of age together with the other routine infant vaccines given at these ages.
Starting September 2017, BC's publicly funded immunization program will include HPV9 vaccine for grade 6 boys. Therefore all grade 6 students in BC, both female and male, will be offered the HPV9 vaccine series for free as part of the regular school-based immunization program. This vaccine may also be provided to eligible students through health care providers and local public health units if missed in the school setting. HPV9 vaccine will be provided as 2 doses given 6 months apart to grade 6 students. For more information please refer to the
Ministry of Health announcement.
